Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInventory AverageInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Unicycive Therapeutics (UNCY) Asset Utilization Ratio (2023)

Unicycive Therapeutics filings provide 1 years of Asset Utilization Ratio readings, the most recent being 0.04 for Q4 2023.

  • On a quarterly basis, Asset Utilization Ratio changed N/A to 0.04 in Q4 2023 year-over-year; TTM through Dec 2023 was 0.04, a N/A change, with the full-year FY2023 number at 0.08, down 10.02% from a year prior.
  • Asset Utilization Ratio hit 0.04 in Q4 2023 for Unicycive Therapeutics, up from 0.03 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.06 in Q2 2023 to a low of 0.03 in Q3 2023.